These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32871811)

  • 1. Subtotal Colectomy as Part of Debulking Surgery for Advanced-stage Ovarian Cancer.
    Bacalbasa N; Diaconu C; Iliescu L; Dima S; Bratu OG; Cretoiu D; Neacsu A; Filipescu A; Savu C; Balescu I
    In Vivo; 2020; 34(5):2757-2761. PubMed ID: 32871811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative outcomes of extensive bowel resection during cytoreductive surgery in patients with advanced ovarian cancer.
    Son JH; Kong TW; Paek J; Chang SJ; Ryu HS
    J Surg Oncol; 2019 Jun; 119(7):1011-1015. PubMed ID: 30737795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
    Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Diaphragmatic Surgery as Part of Cytoreductive Effort in Advanced Stage Ovarian Cancer.
    Bacalbasa N; Balescu I; Balalau C; Ionescu O; Stoica C
    In Vivo; 2018; 32(2):431-436. PubMed ID: 29475933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome.
    Manning-Geist BL; Hicks-Courant K; Gockley AA; Clark RM; Del Carmen MG; Growdon WB; Horowitz NS; Berkowitz RS; Muto MG; Worley MJ
    Am J Obstet Gynecol; 2019 Oct; 221(4):326.e1-326.e7. PubMed ID: 31082382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of residual disease on overall survival in women with Federation of Gynecology and Obstetrics stage IIIB-IIIC vs stage IV epithelial ovarian cancer after primary surgery.
    Sørensen SM; Schnack TH; Høgdall C
    Acta Obstet Gynecol Scand; 2019 Jan; 98(1):34-43. PubMed ID: 30168853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Influence of "Omental Cake" Presence on the Completeness of Cytoreduction in Advanced-stage Ovarian Cancer.
    Bacalbasa N; Diaconu C; Iliescu L; Savu C; Bratu OG; Bolca C; Cretoiu D; Filipescu A; Dima S; Balalau C; Balescu I
    In Vivo; 2020; 34(4):2187-2191. PubMed ID: 32606203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer.
    Morimoto A; Nagao S; Kogiku A; Yamamoto K; Miwa M; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Fujiwara K
    Jpn J Clin Oncol; 2016 Jun; 46(6):517-21. PubMed ID: 26977055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hospital surgical volume on complete gross resection (CGR) rates following primary debulking surgery for advanced stage epithelial ovarian carcinoma.
    Nasioudis D; Kahn R; Chapman-Davis E; Frey MK; Caputo TA; Witkin SS; Holcomb K
    Gynecol Oncol; 2019 Aug; 154(2):401-404. PubMed ID: 31160074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total or subtotal colectomy in patients undergoing surgery for primary or recurrent epithelial ovarian cancer.
    Oseledchyk A; Abramian A; Kaiser C; Debald M; Domröse C; Kiefer N; Putensen C; Pantelis D; Kuhn W; Schäfer N; Keyver-Paik MD
    Oncol Res Treat; 2014; 37(9):448-54. PubMed ID: 25231684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Right Upper Abdominal Resections in Advanced Stage Ovarian Cancer.
    Bacalbasa N; Balescu I; Diaconu C; Iliescu L; Filipescu A; Pop C; Dima S; Vilcu M; Brezean I
    In Vivo; 2020; 34(3):1487-1492. PubMed ID: 32354951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer.
    Turnbull HL; Akrivos N; Wemyss-Holden S; Maiya B; Duncan TJ; Nieto JJ; Burbos N
    Arch Gynecol Obstet; 2017 Mar; 295(3):681-687. PubMed ID: 27995370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.
    Bristow RE; Peiretti M; Gerardi M; Zanagnolo V; Ueda S; Diaz-Montes T; Giuntoli RL; Maggioni A
    Gynecol Oncol; 2009 Aug; 114(2):173-7. PubMed ID: 19482344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total rectosigmoidectomy versus partial rectal resection in primary debulking surgery for advanced ovarian cancer.
    Plotti F; Montera R; Aloisi A; Scaletta G; Capriglione S; Luvero D; De Cicco Nardone C; Basile S; Benedetti Panici P; Angioli R
    Eur J Surg Oncol; 2016 Mar; 42(3):383-90. PubMed ID: 26725211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
    Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
    Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experience with PlasmaJet™ in debulking surgery in 87 patients with advanced-stage ovarian cancer.
    Volcke A; Van Nieuwenhuysen E; Han S; Salihi R; Van Gorp T; Vergote I
    J Surg Oncol; 2021 Mar; 123(4):1109-1114. PubMed ID: 33497468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. En-bloc pelvic resection with concomitant rectosigmoid colectomy and immediate anastomosis as part of primary cytoreductive surgery for patients with advanced ovarian cancer.
    Yildirim Y; Ertas IE; Nayki U; Ulug P; Nayki C; Yilmaz I; Gultekin E; Dogan A; Aykas A; Ulug S; Ozdemir A; Solmaz U
    Eur J Gynaecol Oncol; 2014; 35(4):400-7. PubMed ID: 25118481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal residual disease at primary debulking surgery versus complete tumor resection at interval debulking surgery in advanced epithelial ovarian cancer: A survival analysis.
    Ghirardi V; Moruzzi MC; Bizzarri N; Vargiu V; D'Indinosante M; Garganese G; Pasciuto T; Loverro M; Scambia G; Fagotti A
    Gynecol Oncol; 2020 Apr; 157(1):209-213. PubMed ID: 31952843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.
    Kim HS; Bristow RE; Chang SJ
    Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive surgical strategies in advanced ovarian cancer: a monocentric study of 203 stage IIIC and IV patients.
    Colombo PE; Mourregot A; Fabbro M; Gutowski M; Saint-Aubert B; Quenet F; Gourgou S; Rouanet P
    Eur J Surg Oncol; 2009 Feb; 35(2):135-43. PubMed ID: 18289825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.